PD-ECGF Polyclonal Antibody

TYMP encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified.

The PD-ECGF Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Platelet-Derived Endothelial Cell Growth Factor (PD-ECGF) in various biological samples. This antibody is produced using advanced techniques, ensuring its high affinity and specificity towards PD-ECGF.

The PD-ECGF Polyclonal Antibody exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA). Its superior sensitivity allows for the accurate and reliable detection of PD-ECGF even at low concentrations, making it an invaluable tool for researchers and clinicians alike.

This antibody is manufactured under stringent quality control measures to ensure batch-to-batch consistency and reproducibility. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation steps.

The PD-ECGF Polyclonal Antibody is compatible with various sample types, including cell lysates, tissue homogenates, and serum, enabling its versatile application in diverse research areas such as cancer biology, angiogenesis, and cardiovascular diseases.

With its exceptional specificity, sensitivity, and ease of use, the PD-ECGF Polyclonal Antibody is an indispensable tool for researchers and clinicians seeking to unravel the intricate mechanisms underlying PD-ECGF-related processes.